Gene therapy for tissue repair and regeneration.

[1]  U. Francke,et al.  Mouse latent TGF-beta binding protein-2: molecular cloning and developmental expression. , 1997, Biochimica et biophysica acta.

[2]  R. Crystal,et al.  Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase. , 1997, Circulation.

[3]  J. Wolff.  Naked DNA transport and expression in mammalian cells , 1997, Neuromuscular Disorders.

[4]  A. Clowes.  Vascular Gene Therapy in the 21st Century , 1997, Thrombosis and Haemostasis.

[5]  P. Hobart,et al.  Development of improved vectors for DNA-based immunization and other gene therapy applications. , 1997, Vaccine.

[6]  C B Sledge,et al.  Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro. , 1997, Journal of biomedical materials research.

[7]  T Friedmann,et al.  Overcoming the obstacles to gene therapy. , 1997, Scientific American.

[8]  H. Blau,et al.  Gene therapy: Progress, problems, prospects. , 1997, Nature Medicine.

[9]  P. Felgner.  Nonviral strategies for gene therapy. , 1997, Scientific American.

[10]  S. Davis,et al.  Biomedical applications of nanotechnology--implications for drug targeting and gene therapy. , 1997, Trends in biotechnology.

[11]  R. Blaese,et al.  Gene therapy for cancer. , 1997, Scientific American.

[12]  J. Isner,et al.  Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. , 1997, Journal of the American College of Cardiology.

[13]  D. Curiel,et al.  Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. , 1997, Cancer research.

[14]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[15]  H. Willard,et al.  Formation of de novo centromeres and construction of first-generation human artificial microchromosomes , 1997, Nature Genetics.

[16]  Donald E. Chickering,et al.  Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.

[17]  J. Marini,et al.  Osteogenesis imperfecta. Rehabilitation and prospects for gene therapy. , 1997, JAMA.

[18]  G. Palù.  Combined strategies for gene therapy of AIDS , 1997, Gene Therapy.

[19]  I. Pastan,et al.  In Vivo Drug‐Selectable Genes: A New Concept in Gene Therapy , 1997, Stem cells.

[20]  Robert J. Levy,et al.  Nanoparticle drug delivery system for restenosis , 1997 .

[21]  K. Rice,et al.  Peptide-mediated gene delivery: influence of peptide structure on gene expression. , 1997, Bioconjugate chemistry.

[22]  M. Johnson,et al.  Progression of HIV disease is associated with increased expression of FcγRI and CR1 on alveolar macrophages , 1997, Clinical and experimental immunology.

[23]  Y. Buechler,et al.  Targeting DNA to Cells with Basic Fibroblast Growth Factor (FGF2)* , 1996, The Journal of Biological Chemistry.

[24]  J. Isner,et al.  Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. , 1996, Circulation.

[25]  J. Isner,et al.  Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. , 1996, Circulation.

[26]  T. Friedmann.  The maturation of human gene therapy , 1996, Acta paediatrica.

[27]  J. D. Grausz,et al.  The TMC Worldwide Gene Therapy Enrollment Report (June 1996). , 1996, Human gene therapy.

[28]  A. Fattaey,et al.  An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells , 1996, Science.

[29]  James M. Wilson,et al.  Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs , 1996, Journal of virology.

[30]  J. Isner.  The role of angiogenic cytokines in cardiovascular disease. , 1996, Clinical immunology and immunopathology.

[31]  Shannon R. Magari,et al.  A humanized system for pharmacologic control of gene expression , 1996, Nature Medicine.

[32]  Takayuki Asahara,et al.  Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb , 1996, The Lancet.

[33]  R. Crystal,et al.  Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. , 1996, The Annals of thoracic surgery.

[34]  E. Raz,et al.  Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization , 1996, Science.

[35]  W. Giannobile,et al.  Periodontal tissue engineering by growth factors. , 1996, Bone.

[36]  S. Goldstein,et al.  Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  N. Horikoshi,et al.  Blockage by Adenovirus E4orf6 of Transcriptional Activation by the p53 Tumor Suppressor , 1996, Science.

[38]  D. Schatz,et al.  Diverse strategies for tetracycline-regulated inducible gene expression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Wilson,et al.  Adenoviruses as gene-delivery vehicles. , 1996, The New England journal of medicine.

[40]  J. Leiden,et al.  Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors , 1996, Nature Medicine.

[41]  F. Cohen,et al.  Bone‐selective analogs of human PTH(1–34) increase bone formation in an ovariectomized rat model , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  A. Clowes.  Improving the interface between biomaterials and the blood. The gene therapy approach. , 1996, Circulation.

[43]  T. Friedmann.  Human gene therapy — an immature genie, but certainly out of the bottle , 1996, Nature Medicine.

[44]  G. Widera,et al.  Particle-mediated nucleic acid immunization. , 1996, Journal of biotechnology.

[45]  J. C. Perales,et al.  Receptor-mediated gene transfer into macrophages. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Vacanti,et al.  De Novo Cartilage Generation Using Calcium Alginate‐Chondrocyte Constructs , 1996, Plastic and reconstructive surgery.

[47]  R Langer,et al.  Development of biomechanical properties and morphogenesis of in vitro tissue engineered cartilage. , 1995, Journal of biomedical materials research.

[48]  P. Libby,et al.  Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. , 1995, The Journal of clinical investigation.

[49]  D. Rader,et al.  A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia , 1995, Nature Medicine.

[50]  J. Leiden,et al.  Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. , 1995, The Journal of clinical investigation.

[51]  R. Lindsay,et al.  Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats. , 1995, The Journal of clinical investigation.

[52]  S. Rosenberg,et al.  T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years , 1995, Science.

[53]  P. Hu,et al.  A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. , 1995, The New England journal of medicine.

[54]  J. Galante,et al.  Enhancement of bone ingrowth by transforming growth factor-beta. , 1995, The Journal of bone and joint surgery. American volume.

[55]  R. Turner,et al.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. , 1995, Endocrinology.

[56]  J. Caulfield,et al.  Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34). , 1995, Endocrinology.

[57]  T. Bonner,et al.  Identification and Functional Expression of a Receptor Selectively Recognizing Parathyroid Hormone, the PTH2 Receptor (*) , 1995, The Journal of Biological Chemistry.

[58]  J. Shiver,et al.  Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus , 1995, Nature Medicine.

[59]  T A Einhorn,et al.  Enhancement of fracture-healing. , 1995, The Journal of bone and joint surgery. American volume.

[60]  G. Condorelli,et al.  Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo , 1995, Nature Medicine.

[61]  Jason A. Lowry,et al.  Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. , 1995, Circulation.

[62]  R. Virmani,et al.  In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. , 1995, Circulation.

[63]  R. Mecham,et al.  Isolation of a Novel Latent Transforming Growth Factor-β Binding Protein Gene (LTBP-3) (*) , 1995, The Journal of Biological Chemistry.

[64]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[65]  V. Han,et al.  Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. , 1995, Bone.

[66]  Y. Kaneda,et al.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Derynck,et al.  Toward a molecular understanding of skeletal development , 1995, Cell.

[68]  J. Seltzer,et al.  Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product , 1995, Science.

[69]  A. Klibanski,et al.  Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. , 1994, The New England journal of medicine.

[70]  V. Rosen,et al.  Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713] , 1994, The Journal of cell biology.

[71]  E. Nabel,et al.  Catheter-mediated pulmonary vascular gene transfer and expression. , 1994, Circulation research.

[72]  H. Takahashi,et al.  Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. , 1994, Bone.

[73]  D. Davy,et al.  The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats. , 1994, The Journal of bone and joint surgery. American volume.

[74]  B. A. French,et al.  Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. , 1994, Circulation.

[75]  V. Rosen,et al.  Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[76]  James M. Wilson,et al.  Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans , 1994, Nature.

[77]  R. Crystal,et al.  In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[78]  A. Reddi.  Bone and cartilage differentiation. , 1994, Current opinion in genetics & development.

[79]  R. Derynck,et al.  Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo , 1994, The Journal of cell biology.

[80]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[81]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[82]  E. Nabel,et al.  Gene therapy for vascular smooth muscle cell proliferation after arterial injury. , 1994, Science.

[83]  Woo Seob Kim,et al.  Cartilage Engineered in Predetermined Shapes Employing Cell Transplantation on Synthetic Biodegradable Polymers , 1994, Plastic and reconstructive surgery.

[84]  R Langer,et al.  Joint resurfacing using allograft chondrocytes and synthetic biodegradable polymer scaffolds. , 1994, Journal of biomedical materials research.

[85]  R. Isaacs,et al.  Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[86]  R Langer,et al.  Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytes. , 1994, Biomaterials.

[87]  Robert Langer,et al.  Biodegradable Polymer Scaffolds for Tissue Engineering , 1994, Bio/Technology.

[88]  S. Bloch,et al.  Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression , 1994, Journal of cellular biochemistry.

[89]  S. Cook,et al.  The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. , 1994, The Journal of bone and joint surgery. American volume.

[90]  E. Furth,et al.  Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[91]  K. Takaoka,et al.  Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[92]  K Mechtler,et al.  The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. , 1994, The Journal of biological chemistry.

[93]  James M. Wilson,et al.  Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia , 1994, Nature Genetics.

[94]  N A Peppas,et al.  New challenges in biomaterials. , 1994, Science.

[95]  J. Wozney,et al.  Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[96]  J. Vacanti,et al.  Tissue-engineered growth of cartilage: the effect of varying the concentration of chondrocytes seeded onto synthetic polymer matrices. , 1994, International journal of oral and maxillofacial surgery.

[97]  J. Wozney,et al.  Transforming Growth Factor-β Gene Family Members and Bone* , 1994 .

[98]  O. Tørring,et al.  Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. , 1993, Calcified tissue international.

[99]  R. Lindsay,et al.  Anabolic actions of parathyroid hormone on bone. , 1993, Endocrine reviews.

[100]  J. Isner,et al.  Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. , 1993, Human gene therapy.

[101]  R. Derynck,et al.  Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[102]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[103]  E. Jaffee,et al.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[104]  R. Recker,et al.  The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats. , 1993, Endocrinology.

[105]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[106]  G. Vunjak‐Novakovic,et al.  Cultivation of cell‐polymer cartilage implants in bioreactors , 1993, Journal of cellular biochemistry.

[107]  Blake J. Roessler,et al.  A model system for in vivo gene transfer into the central nervous system using an adenoviral vector , 1993, Nature Genetics.

[108]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[109]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[110]  H. Oppermann,et al.  Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. , 1992, The Journal of biological chemistry.

[111]  Michael Simons,et al.  Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo , 1992, Nature.

[112]  J. Isner,et al.  Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. , 1992, The Journal of clinical investigation.

[113]  M. Siegman,et al.  Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[114]  S. Khosla,et al.  Clinical performance of parathyroid hormone immunometric assays. , 1992, Mayo Clinic proceedings.

[115]  D. Tang,et al.  Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.

[116]  P. C. Rieke,et al.  Innovative materials processing strategies: a biomimetic approach. , 1992, Science.

[117]  J. Leiden,et al.  Systemic delivery of recombinant proteins by genetically modified myoblasts. , 1991, Science.

[118]  H. Blau,et al.  Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. , 1991, Science.

[119]  M. Freeman,et al.  A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. , 1991, Science.

[120]  J. Vacanti,et al.  Synthetic Polymers Seeded with Chondrocytes Provide a Template for New Cartilage Formation , 1991, Plastic and reconstructive surgery.

[121]  H. Reddi,et al.  Tissue transformation into bone in vivo. A potential practical application. , 1991, JAMA.

[122]  O. Tørring,et al.  The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84). , 1991, Endocrinology.

[123]  V. Rosen,et al.  Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro , 1991, The Journal of cell biology.

[124]  R Langer,et al.  Tissue engineering by cell transplantation using degradable polymer substrates. , 1991, Journal of biomechanical engineering.

[125]  B. Hogan,et al.  Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. , 1991, Development.

[126]  R. Mulligan,et al.  Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[127]  J. Hock,et al.  Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone. , 1990, Endocrinology.

[128]  R. Jaenisch,et al.  Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[129]  K. Cornetta,et al.  Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. , 1990, The New England journal of medicine.

[130]  B. Hogan,et al.  Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). , 1990, Development.

[131]  E. Drier,et al.  OP‐1 cDNA encodes an osteogenic protein in the TGF‐beta family. , 1990, The EMBO journal.

[132]  E. Canalis,et al.  Differential effects of continuous and transient treatment with parathyroid hormone related peptide (PTHrp) on bone collagen synthesis. , 1990, Endocrinology.

[133]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[134]  David A. Williams,et al.  Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[135]  B. Hogan,et al.  Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development. , 1989, Genes & development.

[136]  T. Martin,et al.  Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats. , 1989, Endocrinology.

[137]  P. Libby,et al.  Implantation of vascular grafts lined with genetically modified endothelial cells. , 1989, Science.

[138]  R. Brumback,et al.  Early prophylactic bone grafting of high-energy tibial fractures. , 1989, Clinical orthopaedics and related research.

[139]  F. Gage,et al.  Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. , 1988, Science.

[140]  J. Hock,et al.  Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. , 1988, Endocrinology.

[141]  Y. Barrandon,et al.  Expression of an exogenous growth hormone gene by transplantable human epidermal cells. , 1987, Science.

[142]  R. Crystal,et al.  Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo. , 1987, Science.

[143]  F. Ledley,et al.  Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[144]  S. Hansen.  The type-IIIC tibial fracture. Salvage or amputation. , 1987, The Journal of bone and joint surgery. American volume.

[145]  J. Yee,et al.  Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[146]  T. Palmer,et al.  Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[147]  I. Verma,et al.  Towards gene therapy for hemophilia B. , 1987, Molecular biology & medicine.

[148]  Roger D. Kornberg,et al.  Synthetic peptides as nuclear localization signals , 1986, Nature.

[149]  P. Byers,et al.  Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II , 1985, Nature.

[150]  F. Behrens,et al.  Unilateral external fixation for severe open tibial fractures. Preliminary report of a prospective study. , 1983, Clinical orthopaedics and related research.

[151]  L. Fleming,et al.  Open fractures of the tibia treated with the Lottes nail. , 1983, The Journal of bone and joint surgery. American volume.

[152]  J. Heersche,et al.  Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. , 1982, Endocrinology.

[153]  L. Klenerman,et al.  ANABOLIC EFFECT OF LOW DOSES OF A FRAGMENT OF HUMAN PARATHYROID HORMONE ON THE SKELETON IN POSTMENOPAUSAL OSTEOPOROSIS , 1976, The Lancet.

[154]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[155]  P. Astrup,et al.  The acid-base metabolism. A new approach. , 1960, Lancet.

[156]  A. Ham.  A HISTOLOGICAL STUDY OF THE EARLY PHASES OF BONE REPAIR , 1930 .

[157]  Morgan Ra.  Gene therapy for HIV infection. , 1997 .

[158]  J. Goulet,et al.  Delayed union and nonunion of tibial shaft fractures. , 1997, Instructional course lectures.

[159]  J. Isner.  Angiogenesis for revascularization of ischaemic tissues. , 1997, European Heart Journal.

[160]  W. Marasco.  Intrabodies: turning the humoral immune system outside in for intracellular immunization , 1997, Gene Therapy.

[161]  J. Wilson,et al.  Vectors--shuttle vehicles for gene therapy. , 1997, Clinical and experimental immunology.

[162]  T. Martin,et al.  Some aspects of the anabolic action of parathyroid hormone. , 1995, Mineral and Electrolyte Metabolism.

[163]  Von der Leyen.  Gene therapy inhibiting neointimal vascular lesion , 1995 .

[164]  T. Sone,et al.  A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis. , 1995, Mineral and electrolyte metabolism.

[165]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[166]  R Langer,et al.  Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. , 1993, Journal of biomedical materials research.

[167]  J. Hock,et al.  Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats. , 1989, Bone.

[168]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[169]  J. Simon,et al.  The value of posterolateral bone-grafting for non-union of the tibia. , 1984, Acta orthopaedica Belgica.